# Potassium chloride extended release

NDC: 0574-0275
Generic name: Potassium chloride
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20151211
Marketing ended: 20260531
FDA application: ANDA205993

## Active ingredients

- POTASSIUM CHLORIDE: 750 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-0275"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-0275
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef2f9647-00b5-439c-9ec6-2cbfe6bf3f3d